Research Roundup

Debbie Rigby rounds up the latest in research news Dual bronchodilation for the treatment of COPD Dual bronchodilation with long-acting muscarinic receptor antagonists (LAMAs) and long-acting β-agonists (LABAs) fixed dose combinations are more effective than monotherapy for the treatment of patients with COPD. All LAMA/LABA FDCs are consistently more effective than LAMA or LABA administered